.2021 .. Pan Afr Med J, 39(1) : 20.
Perdana NR,Mochtar CA,Umbas R,Hamid ARA .2017 .The risk factors of prostate cancer and its prevention: a literature review. Acta Med Indones, 48(3) : 228-38.
Kimura T,Egawa S. .2018 .Epidemiology of prostate cancer in Asian countries. Int J Urol, 25(6) : 524-31.
Tian JY,Guo FJ,Zheng GY,Ahmad AJC .2018 .Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities. Carcinogenesis, 39(3) : 307-17.
Moris L,Cumberbatch MG,Van den Broeck T,Gandaglia G,Fossati N,Kelly B .2020 .Benefits and risks of primary treatments for high-risk localized and locally advanced prostate cancer: an international multidisciplinary systematic review. Eur Urol, 77(5) : 614-27.
Nguyen D,Long T,Jia X,Lu W,Gu X,Iqbal Z . .A feasibility study for predicting optimal radiation therapy dose 1. , : .
.2019 .6. distributions of prostate cancer patients from patient anatomy using deep learning. Sci Rep, 9(1) : 1076.
Potters L,Morgenstern C,Calugaru E,Fearn P,Jassal A,Presser J .2008 .-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol, 179(5 Suppl)) : S20-4.
Fossati N,Willemse PM,van den Bergh RCN,Yuan CY,Briers E .2017 .The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. Eur Urol, 7291 : 84-109.
Pan HY,Jiang J,Hoffman KE,Tang C,Choi SL,Nguyen QN .2018 .Comparative toxicities and cost of intensity-modulated radiotherapy, proton radiation, and stereotactic body radiotherapy among younger men with prostate cancer. J Clin Oncol, 36(18) : 1823-30.
Valle LF,Lehrer EJ,Markovic D,Elashoff D,Levin-Epstein R,Karnes RJ .2021 .A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer. Eur Urol, 80(3) : 280-92.
Roach M 3rd,Hanks G,Thames H,Schellhammer P,Shipley WU,Sokol GH .2006 .Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys, 65(4) : 965-74.
Hanif S,Osmani AH,Mallick J .2024 .Treatment Related Acute Toxicities Between Treatment with 3D-CRT and IMRT in Localised Prostate Cancer. J Coll Physicians Surg Pak, 34(5) : 573-7.
Akhtar S,Hassan F,Ahmad S,El-Affendi MA,Khan MI .2023 .The prevalence of prostate cancer in Pakistan: A systematic review and meta-analysis. Heliyon, 9(10) : e20350.
Siri FH,Salehiniya H .2020 .Prostate cancer in Iran: an epidemiological review. J Gastrointest Cancer, 51 : 418-24.
Bosland MC,Nettey OS,Phillips AA,Anunobi CC,Akinloye O,Ekanem IA .2021 .Prevalence of prostate cancer at autopsy in Nigeria-a preliminary report. Prostate, 81(9) : 553-9.
Viani G,Hamamura AC,Faustino AC .2019 .Intensity modulated radiotherapy (IMRT) or conformational radiotherapy (3DCRT) with conventional fractionation for prostate cancer: Is there any clinical difference?. Int Braz J Urol, 45(6) : 1105-12.
Fischer-Valuck BW,Rao YJ .2018 .Intensitymodulated radiotherapy for prostate cancer. Transl Androl Urol, 7(3) : 297.
Konski AJTa .2018 .Cost effectiveness of prostate cancer radiotherapy. Transl Androl Urol, 7(3) : 371-7.
Pettersson A,Robinson D,Garmo H,Holmberg L,Stattin P .2018 .Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study. Ann Oncol, 29(2) : 377-85.
Malik SS,Batool R,Masood N,Yasmin A .2018 .Risk factors for prostate cancer: A multifactorial case-control study. Curr Probl Cancer, 42(3) : 337-43.
Tsodikov A,Gulati R,de Carvalho TM,Heijnsdijk EA,Hunter‐Merrill RA,Mariotto AB .2017 .Is prostate cancer different in black men? Answers from 3 natural history models. Cancer, 123(12) : 2312-19.
Arthur R,Williams R,Garmo H,Holmberg L,Stattin P,Malmström H .2018 .Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study. Int J Cancer, 142(11) : 2254-62.
Fukuokaya W,Kim S,Natsuyama T,Matsuzaki K,Shiomi H,Kitoh H .2018 .Significance of prostate-specific antigen kinetics after three-dimensional conformal radiotherapy with androgen deprivation therapy in patients with localized prostate cancer. Int J Clin Oncol, 23(2) : 361-7.
Parikh RR,Byun J,Goyal S,Kim IY .2017 .Local therapy improves overall survival in patients with newly diagnosed metastatic prostate cancer. Prostate, 77(6) : 559-72.
Inaba K,Tsuchida K,Kashihara T,Umezawa R,Takahashi K,Okuma K .2021 .Treatment results of radiotherapy to both the prostate and metastatic sites in patients with bone metastatic prostate cancer. J Radiat Res, 62(3) : 511-6.
Takano S,Shibamoto Y,Takemoto S,Sugie C,Manabe Y,Yanagi T .2020 .PSA Levels after IMRT for Prostate Cancer: Discriminating Second Plateau from PSA Failure. Int J Radiat Oncol Biol Phys, 108(3) : e890.
Dutz A,Baumann M,Krause M. Early .2019 .and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer. Acta Oncol, 58(6) : 916-25.
Carrier F,Liao Y,Mendenhall N,Guerrieri P,Todor D,Ahmad A .2019 .Three Discipline Collaborative Radiation Therapy (3DCRT) Special Debate: I would treat prostate cancer with proton therapy. J Appl Clin Med Phys, 20(7) : 7-14.
Barber L,Gerke T,Markt SC,Peisch SF,Wilson KM,Ahearn T .2018 .Family history of breast or prostate cancer and prostate cancer risk. Clin Cancer Res, 24(23) : 5910-7.
Akhtar S,Ali A,Ahmad S,Khan MI,Shah S,Hassan F. .2022 .The prevalence of foot ulcers in diabetic patients in Pakistan: a systematic review and meta-analysis. Front Public Health, 10 : 1017201.
Akhtar S,Ramzan M,Shah S,Ahmad I,Khan MI,Ahmad S .2022 .Forecasting exchange rate of Pakistan using time series analysis. Math Probl Eng, : 9108580.
.2024 .. Submitted: November, 15 : .